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Intermittent claudication is a common complaint, with 2392 articles recorded on PUBMED dealing with
‘‘health related quality of life in the English language’’a prevalence of 5% in men older than 50 years. Patients
presenting with symptomatic lower-limb arterial dis- 72% were published in the period 1995–1999, with
only 5% in the period 1985–1989. Less than 30 of theseease commonly have associated ischaemic heart and
cerebrovascular disease, explaining their three-fold articles relate quality of life to outcome of vascular
treatment. Treatment protocols and individual patientincreased mortality rate compared to matched con-
trols.1 The principal initial management is attention to management require the development and application
of standardised patient-assessed measures of healththe risk factors for atherosclerosis, by patient edu-
cation, control of hypercholesterolaemia, hypertension outcome. Two forms of such assessment exist: generic
and disease-specific. Generic instruments can be usedand diabetes mellitus, and use of nicotine replacement
therapy.1 Lifestyle-limiting leg symptoms will require for patients with any disease state. Examples include
the Short Form 36-Item Health Survey (SF-36)5 andconsideration of therapy by exercise rehabilitation,
angioplasty or reconstructive surgery.1 The Nottingham Health Profile (NHP).6 The SF-36 has
been used most widely and, since a large componentTraditionally, outcome following vascular or endo-
vascular surgery has been assessed by clinical ex- of this questionnaire assesses physical function, this
is a suitable instrument for patients with intermittentamination combined with measurement of extremity
blood pressure and imaging of the operated site. Suc- claudication.7 Disease-specific instruments are de-
cess has been quoted in terms of patency of the bypass signed to be administered to patients with a particular
or reconstructed site, and new therapeutic techniques problem and are therefore more likely to identify small
have been judged by their effect on patency rates.2 but important changes in health.
However, patency gives no information on the effect Development of a disease-specific instrument re-
of peripheral ischaemia on the patients’ lifestyle. Es- quires detailed interviews with patients and clinicians,
timation of walking ability by distance has been shown followed by a process of feasibility, validity, reliability
to be inaccurate by both patient and doctor.3 Some and responsiveness assessment.8 An example of a dis-
vascular laboratories use treadmill-walking distances ease-specific instrument for intermittent claudication
to gauge the effect of peripheral arterial disease on is the Walking Impairment Questionnaire (WIQ). This
patients’ walking ability.4 However, treadmill dis- questionnaire has been extensively compared with
tances are unlikely to give a good guide to the influence other measures of lower limb ischaemia, such as tread-
of intermittent claudication on a particular patient’s mill-walking distance and ankle blood pressure.9 How-
life. ever, the WIQ does rely on the patients’ estimate of
Patient-assessed measures of health outcome are walking distance, which is known to be inaccurate,3
gaining increasing acceptance, as reflected by the in- and is a narrow reflection of the impact of intermittent
creasing number of publications in this area. Of the claudication on the individual patient. A patient-as-
sessed measure of health outcome that quantifies the
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